Targeting AVIL, a New Cytoskeleton Regulator in Glioblastoma

Targeting AVIL, a New Cytoskeleton Regulator in Glioblastoma

Glioblastoma (GBM) is the most common adult neural malignancy and the deadliest. The standard of care is optimal, safe, cytoreductive surgery followed by combined radiation therapy and alkylating chemotherapy with temozolomide. Recurrence is common and therapeutic options in the recurrent setting ar...

Full description

Bibliographic Details
Main Authors: Robert Cornelison, Laine Marrah, Drew Horter, Sarah Lynch, Hui Li
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
glioblastoma
AVIL
FOXM1
LIN28B
actin
gelsolin
Online Access:https://www.mdpi.com/1422-0067/22/24/13635

Similar Items

Similar Items